Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-55441 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- SMARCC1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: AHVKKVQEAA RASGKVDPTY GLESSCIAGT GPDEPEKLEG AEEEKMEADP DGQQPEKAEN KVENETDEGD KAQDGENEKN SEKEQDSEVS EDTKSEEKET EENKELTDTC KERESDTGKK KVEHEISEGN VATAAAAALA SAATKAKHL
- Concentration
- 0.05 mg/mL
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of SMARCC1 in human cell line NTERA-2 using a SMARCC1 Polyclonal Antibody (Product # PA5-55441).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of SMARCC1 in human cell line U-2 OS shows positivity in nucleus but excluded from the nucleoli. Samples were probed using a SMARCC1 Polyclonal Antibody (Product # PA5-55441).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of SMARCC1 in human testis and skeletal muscle tissues using SMARCC1 Polyclonal Antibody (Product # PA5-55441). Corresponding SMARCC1 RNA-seq data are presented for the same tissues.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of SMARCC1 in human testis using SMARCC1 Polyclonal Antibody (Product # PA5-55441) shows high expression.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of SMARCC1 in human skeletal muscle using SMARCC1 Polyclonal Antibody (Product # PA5-55441) shows low expression as expected.
